<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(1)</volume><submitter>Palmer A</submitter><journal>Blood cancer journal</journal><pagination>158</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12501014</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Assessing drivers of disparate outcomes and applicability of risk stratification in a cohort of patients with myelofibrosis.</pubmed_title><pmcid>PMC12501014</pmcid><pubmed_authors>Dunton A</pubmed_authors><pubmed_authors>Rauscher G</pubmed_authors><pubmed_authors>Erra A</pubmed_authors><pubmed_authors>Tsai SB</pubmed_authors><pubmed_authors>Au C</pubmed_authors><pubmed_authors>Abraham I</pubmed_authors><pubmed_authors>Altman JK</pubmed_authors><pubmed_authors>Africawala N</pubmed_authors><pubmed_authors>Odenike O</pubmed_authors><pubmed_authors>Schoen A</pubmed_authors><pubmed_authors>Stock W</pubmed_authors><pubmed_authors>Khan I</pubmed_authors><pubmed_authors>Nassar A</pubmed_authors><pubmed_authors>Burkart M</pubmed_authors><pubmed_authors>Palmer A</pubmed_authors><pubmed_authors>O'Hara A</pubmed_authors><pubmed_authors>Dave A</pubmed_authors><pubmed_authors>Zia M</pubmed_authors><pubmed_authors>Solipuram V</pubmed_authors><pubmed_authors>Rondelli D</pubmed_authors><pubmed_authors>Patel AA</pubmed_authors><pubmed_authors>Zhu S</pubmed_authors><pubmed_authors>Larson ML</pubmed_authors></additional><is_claimable>false</is_claimable><name>Assessing drivers of disparate outcomes and applicability of risk stratification in a cohort of patients with myelofibrosis.</name><description/><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-04T05:33:39.738Z</modification><creation>2026-05-05T03:13:10.098Z</creation></dates><accession>S-EPMC12501014</accession><cross_references><pubmed>41053057</pubmed><doi>10.1038/s41408-025-01366-x</doi></cross_references></HashMap>